Immune complex-mediated antigen presentation induces tumor immunity

Journal of Clinical Investigation

Volumn 110, Issue 1, 2002, Pages 71-79

  Rafiq, Khadija ^a   Bergtold, Amy ^a   Clynes, Raphael ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DISEASE ASSOCIATION; ENDOCYTOSIS; HUMORAL IMMUNITY; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TUMOR IMMUNITY; VACCINATION;

EID: 0036307752     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215640     Document Type: Article

References (47)

1. Cross-presentation, dendritic cells, tolerance and immunity
2. Class-I restricted processing and presentation of exogenous cell associated antigen in vivo
3. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
4. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
5. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis
6. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
7. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells
8. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses
9. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
10. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
11. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells
12. Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells
13. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo
14. Divergent roles for Fc receptors and complement in vivo
15. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene
16. Fc receptors are required in passive and active immunity to melanoma
17. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
18. Synergy between an antibody and CD8+ cells in eliminating an established tumor
19. Regulation of antibody responses via antibodies, complement, and Fc receptors
20. Antigen-macrophage interaction. II. Relative roles of cytophilic antibody and other membrane sites
21. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen
22. The immune complex: Possible ways of regulating the antibody response
23. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
24. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow
25. Transport of peptide-MHC class II complexes in developing dendritic cells
26. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production
27. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3
28. FcR gamma chain deletion results in pleiotrophic effector cell defects
29. Immunobiology of dendritic cells
30. The role of CD4+ T cell responses in antitumor immunity
31. CD4 T cells and their role in antitumor immune responses
32. Functional diversity of helper T lymphocytes
33. Improving the efficacy of antibody-based cancer therapies
34. Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma
35. Dendritic cells: Specialized and regulated antigen processing machines
36. Fc receptor signaling and trafficking: A connection for antigen processing
37. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
38. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses
39. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice
40. Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice
41. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
42. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: Implications for the clinical use of dendritic cells
43. Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens
44. Increased potency of Fc-receptor-targeted antigens
45. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection
46. Immune inhibitory receptors
47. Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens